Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial (Q82983072)
Jump to navigation
Jump to search
scientific article published on 22 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial |
scientific article published on 22 December 2010 |
Statements
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial (English)
Allan Iversen
Ulrik Abildgaard
Anders Galloe
Soren Galatius
Jan K Madsen
Thomas Engstroem
Sune Pedersen
Kurt S Jensen
22 December 2010